BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Saint Health Group//Regulatory Radar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:us-dea-407-deadline--compliance@sainthealthgroup.com
DTSTAMP:20261001T000000Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:[US] Compliance deadline: DEA telemedicine flexibilities for contro
 lled substance prescribing expire December 31
DESCRIPTION:Programs prescribing buprenorphine or other controlled medicati
 ons by telehealth without a prior in-person exam should plan for January 2
 027 now. Identify affected patients and schedule in-person visits or alter
 natives in case no further extension is issued.\n\nOfficial notice: https:
 //www.federalregister.gov/documents/2025/12/31/2025-24123/fourth-temporary
 -extension-of-covid-19-telemedicine-flexibilities-for-prescription-of-cont
 rolled\nRegulatory Radar: https://www.sainthealthgroup.com/radar/2026-10-0
 1#us-dea-407-deadline
URL:https://www.sainthealthgroup.com/radar/2026-10-01#us-dea-407-deadline
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR